Continuation of thiazolidinedione therapy in patients without left ventricular dysfunction who developed edema and congestive-heart-failure symptoms

Am J Health Syst Pharm. 2004 Aug 1;61(15):1604-8. doi: 10.1093/ajhp/61.15.1604.
No abstract available

Publication types

  • Case Reports

MeSH terms

  • Aged
  • Aged, 80 and over
  • Diabetes Mellitus, Type 2 / drug therapy*
  • Dose-Response Relationship, Drug
  • Edema / chemically induced*
  • Female
  • Heart Failure / chemically induced*
  • Humans
  • Hypoglycemic Agents / administration & dosage
  • Hypoglycemic Agents / adverse effects*
  • Hypoglycemic Agents / therapeutic use
  • Ligands
  • Male
  • Middle Aged
  • Thiazolidinediones / administration & dosage
  • Thiazolidinediones / adverse effects*
  • Thiazolidinediones / therapeutic use

Substances

  • Hypoglycemic Agents
  • Ligands
  • Thiazolidinediones
  • 2,4-thiazolidinedione